DashboardAll companies
Run this on your own research
Healthcare · Diagnostics & Research

Labcorp Holdings Inc.

LHNYSE$328.95−$0.98 (−0.30%)Market closed

Price Chart

Daily

Key facts

Market Cap
$26.88B
P/E
31.2x
P/B
3.18x
ROE
10.5%

Labcorp Holdings Inc.

Healthcare · Diagnostics & Research · FY 2025

Labcorp Holdings Inc. operates as a company providing comprehensive laboratory services across a variety of health disciplines. As a leader in diagnostic testing, Labcorp offers an extensive range of clinical laboratory services, from routine blood tests to sophisticated genetic analyses. These services are critical for enabling healthcare providers to diagnose, manage, and prevent diseases effectively. Labcorp is significant in its role supporting hospitals, physicians, and researchers by providing the necessary tools for medical assessment and scientific inquiry. The company is also engaged in drug development and commercialization through its subsidiary, Covance, which plays a pivotal role in pharmaceutical and biotechnological research. Labcorp’s operations are crucial in sectors such as oncology, cardiology, endocrinology, and infectious diseases, impacting how these fields advance in terms of research and patient care. Headquartered in Burlington, North Carolina, Labcorp has established itself as a vital contributor to the healthcare infrastructure, advancing patient outcomes and pioneering medical innovation since its inception in 1978.

CEO
Mr. Adam H. Schechter
Employees
60,900

Company Statistics

Valuation

P/E
31.2x
P/B
3.18x
P/S
1.96x
EV/EBITDA
15.7x
P/FCF
22.7x

Margins

Gross
28.8%
EBITDA
15.3%
Operating
10.9%
Pre-Tax
7.9%
Net
6.3%

Returns

ROA
4.8%
ROE
10.5%
ROIC
7.2%

Growth (CAGR)

Rev 3Yr
5.6%
Rev 5Yr
−0.0%
Op Inc 3Yr
−4.7%
Net Inc 3Yr
−11.8%

Financial Health

Cash & Cash Equivalents
$532.3M
Net Debt
$9.22B
Debt/Equity
113.0%
Interest Cov
—

Profile

Revenue
$13.95B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Labcorp Holdings Inc. (LH) Stock Forecast 2026 $328.95 — Price, Financials & Analyst Targets | AlphaLenz